.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Breast cancer care often involves complex treatment regimens that can significantly impact a patient’s well-being. A recent randomized controlled trial highlights how a well-structured Chemotherapy Order Template led by oncology pharmacists can transform patient outcomes. This study specifically evaluated the tool's impact on quality of life (QoL) for patients receiving paclitaxel. By standardizing the prescribing process, clinicians can ensure that every patient receives consistent, evidence-based care.
Researchers randomly assigned 168 breast cancer patients to either a routine documentation group or a standardized template group. Those in the intervention group showed significant and progressive improvements in FACT-G quality-of-life scores. Meanwhile, the control group experienced non-significant changes throughout the study. Although both groups reported similar adverse reactions, the structured group benefited from more robust safety processes. Consequently, pharmacist-led templates strengthen supportive care and promote safer prescribing practices.
Standardized order sets facilitate better communication between oncology pharmacists and physicians. Furthermore, they provide a reliable framework for monitoring patient safety and managing side effects. Therefore, implementing these tools in tertiary care settings is a vital step toward patient-centered oncology. This approach ensures that treatment protocols align with the latest clinical guidelines. Moreover, structured documentation reduces the cognitive load on healthcare providers, allowing them to focus more on direct patient interaction.
It provides a validated and standardized framework that reduces prescribing errors and ensures consistent supportive care for every patient.
No, the incidence of adverse reactions like those related to paclitaxel was similar across both groups. However, the template group reported better overall quality of life.
The oncology pharmacist leads the development and validation of the template. They act as a critical checkpoint to ensure that therapy aligns with established safety standards and patient-reported outcomes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
Patil V et al. Impact of an oncology pharmacist-led, well-developed and validated chemotherapy order template on quality of life in breast cancer patients: A randomized controlled trial. J Oncol Pharm Pract. 2026 Mar 27. doi: 10.1177/10781552261434114. PMID: 41891196.
National Comprehensive Cancer Network (NCCN). NCCN Chemotherapy Order Templates (NCCN COT). 2024.
American Society of Health-System Pharmacists. ASHP guidelines on preventing medication errors with chemotherapy and biotherapy. Am J Health Syst Pharm. 2015;72(8):e6-e35.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A randomized study shows pharmacist-led standardized chemotherapy order templates improve quality of life and treatment safety in breast cancer patients....
6 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
